2024 annual financial data
Dermata Therapeutics 2024 Operating margin
Dermata Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -12,513,242 USD and net income was -12,287,461 USD.
Operating cash flow was -11,162,948 USD.
Get free Dermata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,513,242 USD
- Net income
- -12,287,461 USD
- Operating cash flow
- -11,162,948 USD